About

Rann Marom

CEO

Rann is a seasoned executive with an extensive record planning and executing go-to-market strategies, developing business and scaling innovative Israel-based technology companies globally.

His recent senior management roles include opening the Indian market at RADA, a market-leading software-defined radar company acquired by a global top-10 defense conglomerate, and growing US revenues 5x at an education SAAS company through a strategic partnership. Previously, he was a partner at Veritas, Israel’s first venture capital firm, where he led global fundraising as well as seed and early-stage investments in medical device and communications companies.

Rann holds an MBA from INSEAD and a BSc in Aerospace Engineering from the Technion.

Inbal Eyal

VP Clinical Affairs

Inbal brings over 16 years of experience in global clinical research, with a demonstrated record of successfully leading clinical trials, strategy, and operations.

For the past years, Inbal has led the Clinical Affairs department at Medtronic Yokneam, a global company developing medical technology in various fields. Previously, she held the position of Clinical Affairs Director at Enzymotec Ltd., which operated in both pharmaceutical and nutrition markets.

Inbal possesses a comprehensive knowledge of ICH-GCP, ISO 14155, and FDA regulations. Inbal holds both an M.Sc. in Medical Science and an MBA in Business Administration from the Technion Institute of Technology.

Nitai Hanani

CTO & Co-founder

Over seventeen years of experience in cardiovascular and neuromodulation medical devices field in various R&D, engineering and management positions, from which seven with Enopace Biomedical – pioneering the conceptualization and development of intravascular neurostimulation device for treatment of heart failure.

Involved with companies in the fields of stroke treatment, renal denervation, peripheral interventional, acute kidney injury and ventilation monitoring. B.Sc., M.Sc. in Biomedical Engineering, Technion-IIT, Haifa, Israel Graduate project spun-off as startup (Pneumedicare) for ventilation monitoring.

Conducted research in Cardiac Resynchronization Therapy, awarding him as young investigator award of the Israeli Society for Heart Research (ISHR).

Dr. Yair Feld

Medical Director & Founder

Dr. Yair Feld is the director of structural and interventional cardiology unit at Tzafon Medical Center (Poria) Affiliated with Azrieli Faculty of Medicine, Bar Ilan University.

Prior to that, Yair practiced as interventional cardiologist and head of innovation lab at Rambam Healthcare Campus and performed his fellowship in Sunnybrook Toronto. Yair has over 25 years of experience in managing life science companies and leading innovative research and development projects.

He founded several medical technology companies among which Proarc, HVT, Cathalert Corassist Cardiovascular and Cuspa. Yair received his MD and PhD (physiology and biophysics) from the Technion-Israel Institute of Technology, as well as a BA is Physics from the University of Tel-Aviv.

Jose (“Pepe”) Calle Gordo

Board Member

A global medical device executive with over 30 years of business experience.

Jose has had general management and functional responsibility in a broad spectrum of roles, including General/Executive Management, CEO and Board responsibilities as well as leadership roles in Research & Development, Clinical Research, Market Development and Sales & Marketing. As a pillar of cardiovascular MedTech industry, Jose serves as the director of the PCR innovators day course. Most recently, he served as CEO and director of BIOSENSORS International, where he build a multinational management team an

d lead the transformation and expansion of Biosensors from a start up to a recognized multi-national in Vascular Intervention.

Prior to joining BIOSENSORS, he held several leadership roles at ABBOTT (Structural Heart & Vascular) and GUIDANT.

Jose started his career at Eli Lilly where he had a number of commercial roles with growing responsibility in the field of cardiac devices. Jose Calle Gordo holds an electrical engineering degree (BSc) from the Universidad Politecnica de Madrid, Spain.

Zohar Gendler

Chairman

CEO and managing partner of NGT VC. Former CEO and director of Beta-O2 Technologies (a biomedical company which developed proprietary.

Implantable bio-artificial pancreas) for a period of 8 years, brought the company to one of the world leaders positioning in the area.

Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for a period of 11 years.

Led the establishment and investment in more than 40 companies, such as Prolor Biotech (Opko), Mazor Robotics (Medtronic), Corindus (Siemens), ReWalk (NASDAQ: RWLK) and many others. Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies.

M.Sc. in material engineering, B.Sc. in physics, and MBA, all from the Technion, Israel Institute of Technology